e-Profile Login and ID Quick Search
NABP's 97th Annual Meeting Educational Programs Offer a Wide Range of Knowledge
The National Association of Boards of Pharmacy (NABP) will offer three tracks of continuing pharmaceutical education programming at its 97th Annual Meeting. The meeting will be held May 5-9, 2001, at the Sheraton Seattle Hotel and Towers in Seattle, Wash. Whether you are a state board of pharmacy executive officer, board member, compliance officer, or if you are interested in pharmacy regulation and practice, NABP's Annual Meeting has an educational program option for you. In addition, the Annual Meeting features a session for consumer members of the state boards of pharmacy and a new member seminar for individuals recently appointed to boards.
Executive Officer and Board Member Programming
Among the scheduled educational programs for the Executive Officer and Board Member track is Electronic Prescribing and Electronic Signatures, sponsored by the Walgreen Company. On Sunday, May 6, Vickie B. Seeger of the Drug Enforcement Administration, and Todd Inafuku, executive director of the Hawaii Pharmacists Association, will discuss the regulatory issues and initiatives associated with new technologies and their relations to state boards of pharmacy.
The second program slotted for this track, Legislative and Regulatory Update, will be held on Monday, May 7. Sponsored by Abbott Laboratories, this update session, given by John F. Atkinson, NABP counsel, will consider recent legislative and regulatory initiatives.
Sponsored by Merck & Co, the third program, HRSA Report on Pharmacy Manpower Shortage, will be offered on Tuesday, May 8, and presented by James M. Cultice and Judith A. Cooksey. Cultice is an operations research analyst and technical director for the National Center for Health Workforce Information and Analysis in Health Resources and Services Administration's (HRSA) Bureau of Health Professions. Cooksey is the director of the Illinois Center for Health Workforce Studies at the University of Illinois at Chicago. They will discuss the HRSA report presented to Congress entitled The Pharmacist Workforce: A Study of the Supply and Demand for Pharmacists.Participants will learn the specifics of this important report and gain a better understanding of its implications for the practice of pharmacy and the public health.
Compliance Officer Programming
The Compliance Officer track offers three courses addressing issues that may potentially improve the pharmacy workplace and improve the public health.
On Sunday, May 6, Keith W. Macdonald, executive secretary of the Nevada State Board of Pharmacy and Louis Ling, that Board's counsel, will present Assessing the Pharmacy Workplace - Nevada Survey Results. The Nevada State Board of Pharmacy has begun a first-in-the-nation program of gathering and analyzing data from every pharmacy to assess and improve the pharmacy workplace. Discussed during this session will be the survey's results, the mechanism that was used to conduct the program, and the applicability of the project to other state boards.
The second session of this track, Electronic Prescribing and Electronic Signatures, is sponsored by the US Pharmaceuticals Group of Pfizer, Inc, and will be held Monday, May 7. Regulatory issues and initiatives associated with electronic prescribing technologies and their relevance to board compliance staff will be discussed. The session's presenters will be Kepa Zubeldia, president and chief executive officer of claredi.com; Dan Staniec, executive vice president of external affairs for the National Council for Prescription Drug Programs; and Chief Investigator Richard Morrison of the Washington State Board of Pharmacy.
During Pharmaceutical Care Outcomes: The Compliance Perspective, the third session, on Tuesday, May 8, Massachusetts Board of Registration in Pharmacy's Charles R. Young, executive director, and Fred Frankhauser, quality assurance surveyor, will lead participants through a practical discussion of the components of pharmaceutical care outcomes regulation, as well as suggestions for incorporating the concept into board inspection processes.
Pharmacy Practice Programming
This three-part program will consider chronic pain management issues as they relate to patient care and pharmacy regulation.
Sponsored by the AstraZeneca, Opioids and the Law will be presented on Sunday, May 6, by Howard A. Heit, Assistant Clinical professor of medicine, Georgetown University School of Medicine, and David Joranson, senior scientist and director of the Pain and Policy Studies Group, University of Wisconsin Medical School Comprehensive Cancer Center and director of the World Health Organization Collaborating Center for Policy and Communications in Cancer Care. This session will cover opioid addiction and dependency and the regulatory issues associated with treatment.
On Monday, May 7, Neil Michael Ellison, director of the Palliative Medicine Program at the Geisinger Medical Center, will lead a discussion of the ethics surrounding pain therapies during What's So Bad About Feeling Good? The Ethics of Pain Management. This session is sponsored by Purdue Pharma.
Gregory L. Holmquist, pain and palliative care pharmacist specialist for the Group Health Cooperative of Puget Sound and owner of Palliative Care Strategies, will discuss the pharmacological management of chronic pain during the session titled Hooked on a Feeling: Where Have We Gone Wrong in Managing Pain? on Tuesday, May 8.
Joint CE Programming
The title of the Joint Continuing Education Programming on Tuesday, May 8 is Socratic Dialogue: Regulating for Pharmaceutical Care Outcomes. Barry R. Furrow, dean of faculty at the Widener University School of Law, will lead a Socratic dialogue that considers the opinions of various members of the pharmacy profession, board of pharmacy members and staff, legal counsel, and NABP as they relate to pharmaceutical care regulation
To learn more about the 97th Annual Meeting educational and special programming, call the NABP Meetings Desk at 847/698-6227. Or visit the Association's Web site at www.nabp.net.
Jan Teplitz
